PDMR
|
Ordinary Shares acquired under the AZDBP
|
Pascal Soriot
|
8,853
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
a)
|
Name
|
Pascal Soriot
| |
2
|
Reason for the notification
| ||
a)
|
Position/status
|
Chief Executive Officer
| |
b)
|
Initial notification /Amendment
|
Initial notification
| |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
a)
|
Name
|
AstraZeneca PLC
| |
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4i
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
GB0009895292
| |
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares pursuant to a vesting under the AstraZeneca Deferred Bonus Plan, for nil consideration.
| |
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
0
|
8,853
| ||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
| |
e)
|
Date of the transaction
|
6 March 2023
| |
f)
|
Place of the transaction
|
Outside a trading venue
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AstraZeneca plc published this content on 08 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 March 2023 11:36:02 UTC.